Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.31
+0.27
(+13.24%)
USD |
NASDAQ |
Nov 09, 16:00
2.31
0.00 (0.00%)
After-Hours: 19:58
Bridgebio Oncology Therapeutics Total Return Level : 2.04 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 2.04 |
| November 05, 2026 | 2.17 |
| November 04, 2026 | 2.30 |
| November 03, 2026 | 2.32 |
| November 02, 2026 | 2.31 |
| October 30, 2026 | 2.62 |
| October 29, 2026 | 2.70 |
| October 28, 2026 | 2.80 |
| October 27, 2026 | 2.69 |
| October 26, 2026 | 2.64 |
| October 23, 2026 | 2.66 |
| October 22, 2026 | 2.85 |
| October 21, 2026 | 2.68 |
| October 20, 2026 | 2.72 |
| October 19, 2026 | 2.85 |
| October 16, 2026 | 2.82 |
| October 15, 2026 | 2.95 |
| October 14, 2026 | 2.905 |
| October 13, 2026 | 2.95 |
| October 12, 2026 | 3.26 |
| October 09, 2026 | 3.31 |
| October 08, 2026 | 3.42 |
| October 07, 2026 | 3.44 |
| October 06, 2026 | 3.50 |
| October 05, 2026 | 3.60 |
| Date | Value |
|---|---|
| October 02, 2026 | 3.89 |
| October 01, 2026 | 3.94 |
| September 30, 2026 | 4.10 |
| September 29, 2026 | 3.92 |
| September 28, 2026 | 3.81 |
| September 25, 2026 | 3.95 |
| September 24, 2026 | 3.99 |
| September 23, 2026 | 4.16 |
| September 22, 2026 | 4.66 |
| September 21, 2026 | 4.66 |
| September 18, 2026 | 4.77 |
| September 17, 2026 | 4.89 |
| September 16, 2026 | 4.76 |
| September 15, 2026 | 4.88 |
| September 14, 2026 | 5.05 |
| September 11, 2026 | 4.95 |
| September 10, 2026 | 5.52 |
| September 09, 2026 | 6.755 |
| September 08, 2026 | 8.86 |
| September 04, 2026 | 8.98 |
| September 03, 2026 | 8.90 |
| September 02, 2026 | 8.89 |
| September 01, 2026 | 8.82 |
| August 31, 2026 | 8.80 |
| August 28, 2026 | 8.74 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Korsana Biosciences, Inc. | 31.05 |
| IRulya Therapeutics, Inc. | 31.00 |
| PepGen Inc. | 2.47 |
| Q32 Bio, Inc. | 9.25 |
| Arrowhead Pharmaceuticals, Inc. | 58.16 |